Korro Bio Company
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.
Connections from
Total Funding:
91500000
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
Early Stage Venture
Employee Number:
11-50
Last Funding Type:
Series A
Founded Date:
1/1/2018
Industry:
PharmTech